United States · Bill · HR
H.R. 5997 (115th)
Ensuring Patient Access to Critical Breakthrough Products Act of 2018
Introduced
5 June 2018
Last action
—
Status
Referred to the Subcommittee on Health.
Sponsors
—
Subjects
Discovery layer
Source updated
11 August 2025
Summary
Ensuring Patient Access to Critical Breakthrough Products Act of 2018 This bill (1) allows designated medical breakthrough devices to be temporarily covered under Medicare during a specified transitional period, (2) establishes a process to allow for continued coverage after the transitional period has expired, and (3) modifies other Medicare payment systems relating to new medical technology.
This text is taken from the official record. PoliticalRepo does not editorialize.
Timeline
No timeline events have been ingested for this record yet.
Votes
No vote records are attached yet.
Versions
No version snapshots stored. Document URLs remain at the source.
Documents
3 official files
Introduced in House (text)
Introduced in House (text)
Introduced in House · EN · 5 June 2018
Introduced in House (PDF)
Introduced in House · EN · 5 June 2018
Introduced in House
summary · EN · 5 June 2018
Sponsors
No sponsors or actors listed by the source.
Related records
No cross-record relationships stored yet.
Sources
PoliticalRepo is an index and interpretation layer, not the authoritative legal source.
- Official source: https://www.congress.gov/bill/115th-congress/house-bill/5997
- Open data entity: https://api.congress.gov/v3/bill/115/hr/5997